FDA recommendations for minimisation of Nitrosamine related Imps through formulation design changes

Insightful links on recommendations from FDA for minimising risks through formulation design changes
We have had discussions on this Topic in the community earlier, the enclosed link leads to interesting Insights into this Topic

3 Likes